A Randomized, Open-Label, Single-Dose, Small Study to Evaluate the Safety and Effectiveness of Hydromorphone in Patients With Short Term, Moderate to Severe Postoperative Pain

NCT00411307 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain, Postoperative
Orthopedic Procedures
Analgesia

Interventions

DRUG: OROS hydromorphone HCI

Sponsor

Alza Corporation, DE, USA